CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

JSPRJasper Therapeutics, Inc.

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $0.58 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
Market cap$19.30M
RECENT INSIDER TRADES
  • 2026-07-22 · Ros Matthew E (Chief Operating Officer) · BUY
  • 2026-07-20 · Crutcher Patrick J (Director) · BUY
  • 2025-09-24 · Shizuru Judith Anne (Director) · BUY
  • 2025-09-24 · MARTELL RON (President and CEO) · BUY
  • 2025-09-24 · Lucas Svetlana (Director) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders51
Shares held15,436,675
Value$34.69M
Percent of shares outstanding46.39%
As of quarter end2026-06-30
RECENT NEWS
  • Jasper Therapeutics launches warrant repurchase offer at $0.324 per warrant
  • Jasper Therapeutics announces CFO steps down
  • Jasper Therapeutics presents cash position and catalysts at H.C. Wainwright
  • Jasper Therapeutics appoints Lisa Pitt as Senior Vice President, Regulatory Affairs
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Jasper Therapeutics, Inc. (JSPR) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit